Transforming Acne Treatment and Research with Scarletred®Vision

Understanding Acne Vulgaris: Prevalence and Impact

Acne vulgaris is a widespread dermatological condition, affecting approximately 9.4% of the global population and up to 80–90% of European adolescents. While commonly associated with puberty, adult-onset acne (Acne tarda) affects many men and women in their 30s, 40s, and beyond, posing unique challenges for treatment. In Germany and Austria, 70–80% of teenagers experience acne to some degree.

Acne occurs when hair follicles become clogged with sebum and dead skin cells, providing an environment for bacterial growth. There are different types, including:

• Fungal Acne (Pityrosporum Folliculitis): Caused by yeast buildup in hair follicles, leading to itchy, inflamed pimples.
• Hormonal Acne: Linked to excess sebum production, often affecting adults.
• Nodular Acne: Severe lesions on the skin’s surface with painful, tender lumps underneath.
• Cystic Acne: Deep, pus-filled lesions that can lead to scarring.

Acne - more than skin deep

Acne affects more than physical appearance; it can significantly impact mental health, leading to anxiety, depression, and social withdrawal. For adults, acne challenges societal perceptions of healthy skin, often resulting in added stress and stigma. Addressing both physical symptoms and psychological well-being is critical for comprehensive care.

Current Treatment Strategies

Treating acne requires a multifaceted approach. Topical treatments, such as retinoids and benzoyl peroxide, help clear pores and reduce inflammation, while oral antibiotics target bacterial growth. Hormonal therapies regulate sebum production in women, and severe cases may require isotretinoin under medical supervision. In addition, lifestyle adjustments, including stress management, a healthy diet, and gentle skincare, can support better skin health. In-office procedures like chemical peels and light-based therapies provide further options for improving acne severity and preventing scarring.

Scarletred®Vision: Redefining Acne Monitoring and Research

Scarletred®Vision offers a groundbreaking solution for monitoring and researching acne vulgaris. As a CE-certified Class 1m medical device software, it delivers precise, AI-powered skin imaging that eliminates subjective assessments and streamlines clinical workflows.

Key Features and Benefits

• Objective Acne Quantification: Accurately measures lesion type, size, and distribution over time.
• Progress Monitoring: Tracks treatment efficacy using high-resolution images, enabling tailored therapies.
• Remote Monitoring: Allows patients to upload images from home, facilitating teledermatology and reducing the need for in-person visits.
• Research and Clinical Trials: Provides structured, reproducible data to evaluate new therapies and support robust clinical studies.

Advancing Acne Care with Scarletred®Vision

Scarletred®Vision bridges clinical practice and research with its scalable SaaS platform. It delivers real-time, data-driven insights to support personalized acne treatments for all age groups. Compliant with ICH-GCP and EU-GDPR, it ensures secure, high-quality data handling. By enabling objective treatment evaluation, Scarletred®Vision enhances patient outcomes and accelerates the development of innovative acne therapies, paving the way for precise and effective acne management.

Explore how Scarletred®Vision can revolutionize acne treatment and research. Contact office@scarletred.com to learn more about our innovative platform and its role in advancing dermatological care.